Cocrystal Pharma COCP
NASDAQ COCP
$1.16 +0.02 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Cash & Equivalents (2010 - 2026)

Updated

Cocrystal Pharma (COCP) recorded Cash & Equivalents of $2.24 million in Q2 2026, down 53.6% from $4.84 million a year earlier and down 52.9% from the prior quarter.

Analysis

Cocrystal Pharma (COCP) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Cocrystal Pharma reported Cash & Equivalents of $7.1 million, down 28.5% from FY2024.

  • Annual Cash & Equivalents has declined for four straight years, with a five-year compound annual growth rate of -26.5% (FY2020 to FY2025).
  • Across earlier years, Cash & Equivalents came in at $9.94 million in FY2024 (-62.4%), $26.43 million in FY2023 (-29.0%), $37.22 million in FY2022 (-36.6%) and $58.71 million in FY2021 (+77.8%).
  • The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q1 2018.
  • On a year-over-year basis, Cash & Equivalents has declined for 17 consecutive quarters, with an average decline of 51.8% over the last eight quarters.
  • Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 94.0% in Q3 2021, against a decline of 73.4% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.76 million (Q1 2026), $7.1 million (Q4 2025) and $7.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Cocrystal Pharma 15.72 Mn -6.19 Mn - 2.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.24 Mn
Mar 31, 2026 4.76 Mn
Dec 31, 2025 7.10 Mn
Sep 30, 2025 7.80 Mn
Jun 30, 2025 4.84 Mn
Mar 31, 2025 7.00 Mn
Dec 31, 2024 9.94 Mn
Sep 30, 2024 13.10 Mn
Jun 30, 2024 18.22 Mn
Mar 31, 2024 21.92 Mn
Dec 31, 2023 26.43 Mn
Sep 30, 2023 29.81 Mn
Jun 30, 2023 32.42 Mn
Mar 31, 2023 33.98 Mn
Dec 31, 2022 37.22 Mn
Sep 30, 2022 42.06 Mn
Jun 30, 2022 51.03 Mn
Mar 31, 2022 54.79 Mn
Dec 31, 2021 58.71 Mn
Sep 30, 2021 61.64 Mn
API Access

Cocrystal Pharma Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=COCP&period=max&api_key=YOUR_API_KEY